Pages that link to "Q52230212"
Jump to navigation
Jump to search
The following pages link to Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. (Q52230212):
Displaying 50 items.
- The role of dyslipidemia and statins in venous thromboembolism (Q24793360) (← links)
- Lipid-modifying therapy in the elderly (Q28088296) (← links)
- Secondary prevention of coronary heart disease in the elderly (Q28166213) (← links)
- Treatment of the elderly post-myocardial infarction patient (Q28191018) (← links)
- Cardiovascular medications taken by patients aged >or=70 years hospitalized for acute coronary syndromes before hospitalization and at hospital discharge (Q28194120) (← links)
- Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease (Q28196396) (← links)
- Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE) (Q30787990) (← links)
- Cardiac rehabilitation and secondary prevention programs for elderly cardiac patients (Q30891347) (← links)
- Risk factor prevalence and drug treatment in coronary patients at hospital discharge. Results of a national multicenter registry (3C Program) (Q31955448) (← links)
- Management of type 2 diabetes mellitus in the elderly: special considerations (Q32090951) (← links)
- The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study (Q33514949) (← links)
- Disorders of lipid metabolism and chronic kidney disease in the elderly (Q33589563) (← links)
- The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators (Q33686584) (← links)
- Management of the older person with ventricular arrhythmias (Q33686613) (← links)
- Treatment of Stable Angina Pectoris (Q33699764) (← links)
- Managing dyslipidemia in older adults (Q33790720) (← links)
- Atorvastatin in stroke: a review of SPARCL and subgroup analysis (Q33797634) (← links)
- Geriatric medicine (Q33803694) (← links)
- Statins and their interactions with other lipid-modifying medications: safety issues in the elderly (Q33949348) (← links)
- Use of statin therapy to reduce cardiovascular risk in older patients (Q33984593) (← links)
- Hyperlipidemia (Q33986367) (← links)
- Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy (Q34030905) (← links)
- Is hypercholesterolemia a risk factor and should it be treated in the elderly? (Q34077942) (← links)
- Prevention of cardiovascular events in elderly hypercholesterolemic patients (Q34107146) (← links)
- Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis (Q34109222) (← links)
- Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial (Q34158442) (← links)
- Elderly patients at risk for coronary heart disease or stroke: selecting an ideal product for lipid lowering (Q34186428) (← links)
- Screening and treating adults for lipid disorders. (Q34221135) (← links)
- Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association (Q34224601) (← links)
- Controversies in the treatment of hypercholesterolemia in the elderly: who should be treated and how? (Q34255843) (← links)
- Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions (Q34389584) (← links)
- How well tolerated are lipid-lowering drugs? (Q34400638) (← links)
- Diagnosis and management of myocardial ischemia (angina) in the elderly patient (Q34422226) (← links)
- Trials within trials: confirmatory subgroup analyses in controlled clinical experiments (Q34459832) (← links)
- Differences in statin usage and target-goal achievement between departments at the same hospital (Q34515806) (← links)
- Statinopause (Q34566869) (← links)
- The importance of lipid evaluation and management in the prevention and treatment of acute myocardial infarction (Q34714717) (← links)
- Pharmacologic therapy of lipid disorders in the elderly (Q34714765) (← links)
- Peripheral arterial disease: epidemiology and drug therapy (Q34714773) (← links)
- Prevention of cardiovascular diseases. Coronary artery disease, congestive heart failure, and stroke (Q34993307) (← links)
- Hypolipemic agents for stroke prevention. (Q35008533) (← links)
- The clinical pharmacology of ageing (Q35200040) (← links)
- Lipid-lowering therapy in older persons (Q35232239) (← links)
- Pravastatin: a review of its use in elderly patients (Q35598680) (← links)
- Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study (Q35622601) (← links)
- Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study (Q35624965) (← links)
- Beta-blocker underuse in secondary prevention of myocardial infarction (Q35637982) (← links)
- Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction (Q35654987) (← links)
- Interpretation of drug risk and benefit: individual and population perspectives (Q35678256) (← links)
- Cholesterol management and the reduction of cardiovascular risk (Q35686489) (← links)